➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Merck
Johnson and Johnson
Colorcon
Baxter

Last Updated: April 10, 2021

DrugPatentWatch Database Preview

Litigation Details for VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2018)

Docket   Start Trial Date Filed 2018-09-06
Court District Court, D. New Jersey Date Terminated 2020-08-12
Cause 35:271 Patent Infringement Assigned To Brian R. Martinotti
Jury Demand None Referred To Lois H. Goodman
Parties BAUSCH HEALTH AMERICAS, INC.
Patents 10,342,875; 10,478,601; 10,512,640; 7,214,506; 8,039,494; 8,486,978; 9,302,009; 9,566,272; 9,662,394; 9,861,698; 9,877,955
Attorneys J. BRUGH LOWER
Firms Klehr Harrison Harvey Branzburg & Ellers
Link to Docket External link to docket
Small Molecule Drugs cited in VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. ZYDUS PHARMACEUTICALS (USA) INC.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for VALEANT PHARMACEUTICALS NORTH AMERICA LLC v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2018)

Date Filed Document No. Description Snippet Link To Document
2020-05-07 156 Opinion 1 The patents-in-suit are United States Patent Nos. 7,214,506 (“the’506 patent”), 8,039,494 (…include ’978 patent claims 2 and 21, ’494 patent claim 1, ’009 patent claim 1, ’444 patent claim 9, ’698… (“the ’494 patent”), 8,486,978 (“the ’978 patent”), 9,302,009 (“the ’009 patent”), 9,566,272 (“the …the ’272 patent”), 9,662,394 (“the ’394 patent”), 9,861,698 (“the ’698 patent”) and 9,877,955 (“the ’955…’955 patent”) arising under the United States patent laws, Title 35, U.S.C. § 100 et seq., including External link to document
2020-08-12 180 Order of Dismissal with respect toU.S. Patent Nos. 10,512,640 (the 640 patent); 10,342,875 (the 875 patent); and 10,478,601 …respect to U.S. Patent Nos. 10,512,640 (“the ’640 patent”); 10,342,875 (“the ’875 patent”); and 10,478,…U.S. Patent Nos. 7,214,506 (the 506 Patent), 8,039,494 (the 494 Patent), 8,486,978 (the978 Patent), 9,…the 009 Patent), 9,566,272 (the 272 Patent), 9,662,394 (the 394 Patent), 9,861,698 (the 698 Patent), and…respect to U.S. Patent Nos. 7,214,506 (the “’506 Patent”), 8,039,494 (the “’494 Patent”), 8,486,978 (the External link to document
2021-01-10 214 Opinion infringement of Karen’s patent, U.S. Patent No. 10,478,601 (“the ’601 patent”), by Defendants’ filing…, the United States Patent and Trademark Office (“PTO”) issued the ’601 patent, which describes a solution…bottom portion” and “tip portion” used in the ’601 patent. The chart below sets forth the parties’ proposed… Construction “bottom portion” ’601 patent claim 8 Plain and ordinary “the lateral… holder” “tip portion” ’601 patent claim 8 Plain and ordinary “fan-shaped External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck
Express Scripts
Johnson and Johnson
McKesson
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.